Diteba has developed a novel in vitro approach to qualify acyclovir cream products for biowaiver status in accordance with the recently released FDA draft guidance on acyclovir.   This compliant approach combines Diteba’s extensive acyclovir in vitro release testing (IVRT) and in vitro skin permeation testing (IVPT) with the relevant clinical and statistical capabilities of Nutrasource’s regulated products division. This approach provides drug companies with the option to utilize biowaiver in ...